The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC

Clinical trial NCT02915432 · UNKNOWN

Trial details

NCT number: NCT02915432
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Esophageal Squamous Cell Carcinoma Nasopharyngeal Carcinoma Head and Neck Squamous Cell Carcinoma

Start date: 2016-12-01
Primary completion: 2020-02-19
Enrollment: 401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.